Inflammation Phenotypes in Pediatric Sepsis Induced Multiple Organ Failure

小儿脓毒症引起的多器官衰竭的炎症表型

基本信息

项目摘要

Overwhelming infection and sepsis causing many vital organs to fail remains a leading cause of mortality in America's children and in children the world over. Present management includes antibiotics to kill germs and the use of organ support machines for failing organs without any standard use of inflammation based therapies. Among the children who receive this standard of care approach many live but too many others die. The reasons for these divergent outcomes remain an important knowledge gap. We wondered whether insight might be gained from considering the very different approach used in inflammation induced multi system organ failure caused by rheumatologic disease. Standard of care in pediatric rheumatology identifies inflammation pathobiology phenotypes unique to rheumatologic disease and then uses phenotype specific therapies directed to reducing inflammation reflected by biomarkers such as C-reactive protein (CRP) and ferritin. Examining this paradigm in sepsis, we performed a single center study and found that three inflammation pathobiology phenotypes unique to sepsis were related to death from multiple organ failure. Furthermore, evolution of CRP and ferritin responses within these phenotypes were associated with outcome . We propose to assess the clinical relevance of these observations to the nation's children by performing an observational cohort study in 400 sepsis patients recruited from within the NICHD Collaborative Pediatric Critical Care Research Network (CPCCRN) addressing three specific aims: 1) Determine the incidence and outcomes of three unique sepsis MOF phenotypes: Thrombocytopenia Associated MOF defined by three organ failure with new onset thrombocytopenia, renal dysfunction, and an ADAMTS 13 activity < 57%; Immunoparalysis / Lymphoid Depletion associated MOF defined by an ex vivo whole blood endotoxin stimulated TNF response < 200 pg/mL after 3 days; and Sequential MOF defined by respiratory distress followed by liver dysfunction with sFasL level > 200 ng/mL, in children with severe sepsis; 2) Determine the relative contribution of genetic and environmental risk factors to the development of each of these three sepsis induced MOF phenotypes; and 3) Demonstrate that systemic inflammation reflected by CRP and / or Ferritin levels is increased in children with these sepsis induced MOF phenotypes with changes in CRP and Ferritin levels over time being associated with outcomes. If national outcomes are found to be related to this spectrum of inflammation pathobiology and systemic inflammation biomarker responses then further studies of use of phenotype specific therapies directed to normalizing CRP and Ferritin levels in children with severe sepsis induced MOF will be warranted.
导致许多重要器官衰竭的压倒性感染和败血症仍然是 美国儿童和全世界儿童的死亡率。目前的管理包括抗生素致死 细菌和使用器官支持机治疗衰竭器官,而不是任何标准的炎症使用 以治疗为基础。在接受这种标准护理方法的儿童中,许多人活着,但太多了 其他人会死。造成这些不同结果的原因仍然是一个重要的知识鸿沟。我们想知道 是否可以通过考虑在引起炎症时使用的非常不同的方法来获得洞察力 风湿病引起的多系统器官衰竭。儿科风湿病的护理标准 确定风湿性疾病特有的炎症病理生物学表型,然后使用表型 针对C-反应蛋白(CRP)等生物标志物反映的炎症的特定治疗 还有铁蛋白。在脓毒症患者中,我们进行了一项单中心研究,发现有三个 脓毒症特有的炎症病理生物学表型与多器官衰竭死亡有关。 此外,这些表型中的CRP和铁蛋白反应的演变与预后相关。 我们建议通过执行一项调查来评估这些观察结果对全国儿童的临床相关性 NICHD儿科协作中心招募的400例脓毒症患者的观察性队列研究 重症监护研究网络(CPCCRN)针对三个具体目标: 1)确定脓毒症多器官功能衰竭的三种独特表型:血小板减少症的发生率和结局 相关多器官功能衰竭由三个器官衰竭定义,包括新发的血小板减少症、肾功能不全、 和ADAMTS 13活性&lt;57%;免疫麻痹/淋巴衰竭相关的MOF,定义如下 体外全血内毒素刺激的肿瘤坏死因子反应3天后为200pg/mL; 多器官功能衰竭的定义是呼吸窘迫,随后是肝功能障碍,sFasL水平&gt;200 ng/mL,in 严重脓毒症患儿; 2)确定遗传和环境风险因素对发展的相对贡献 这三种败血症均可诱导多器官功能衰竭表型; 3)证明由C反应蛋白和/或铁蛋白水平反映的全身炎症在 这些脓毒症的儿童诱导多器官功能衰竭表型,并随时间改变CRP和铁蛋白水平 与结果相关。 如果国家的结果被发现与这种炎症、病理生物学和全身性疾病的范围有关 炎症生物标记物的反应,然后进一步研究表型特异性治疗的使用 严重脓毒症所致多器官功能衰竭患儿的C反应蛋白和铁蛋白水平正常化是必要的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOSEPH A CARCILLO其他文献

JOSEPH A CARCILLO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOSEPH A CARCILLO', 18)}}的其他基金

Collaborative Pediatric Critical Care Research Network - Clinical Site
儿科重症监护协作研究网络 - 临床网站
  • 批准号:
    10470944
  • 财政年份:
    2021
  • 资助金额:
    $ 54.94万
  • 项目类别:
Collaborative Pediatric Critical Care Research Network - Clinical Site
儿科重症监护协作研究网络 - 临床网站
  • 批准号:
    10393865
  • 财政年份:
    2021
  • 资助金额:
    $ 54.94万
  • 项目类别:
Collaborative Pediatric Critical Care Research Network - Clinical Site
儿科重症监护协作研究网络 - 临床网站
  • 批准号:
    10667510
  • 财政年份:
    2021
  • 资助金额:
    $ 54.94万
  • 项目类别:
Collaborative Pediatric Critical Care Research Network - Clinical Site
儿科重症监护协作研究网络 - 临床网站
  • 批准号:
    10468854
  • 财政年份:
    2021
  • 资助金额:
    $ 54.94万
  • 项目类别:
Collaborative Pediatric Critical Care Research Network - Clinical Site
儿科重症监护协作研究网络 - 临床网站
  • 批准号:
    10670273
  • 财政年份:
    2021
  • 资助金额:
    $ 54.94万
  • 项目类别:
Collaborative Pediatric Critical Care Research Network - Clinical Site
儿科重症监护协作研究网络 - 临床网站
  • 批准号:
    10248823
  • 财政年份:
    2021
  • 资助金额:
    $ 54.94万
  • 项目类别:
Inflammation Phenotypes in Pediatric Sepsis Induced Multiple Organ Failure
小儿脓毒症引起的多器官衰竭的炎症表型
  • 批准号:
    8795738
  • 财政年份:
    2014
  • 资助金额:
    $ 54.94万
  • 项目类别:
Inflammation Phenotypes in Pediatric Sepsis Induced Multiple Organ Failure Renewal
小儿脓毒症引起的多器官衰竭更新的炎症表型
  • 批准号:
    10458632
  • 财政年份:
    2014
  • 资助金额:
    $ 54.94万
  • 项目类别:
Inflammation Phenotypes in Pediatric Sepsis Induced Multiple Organ Failure Renewal
小儿脓毒症引起的多器官衰竭更新的炎症表型
  • 批准号:
    10207661
  • 财政年份:
    2014
  • 资助金额:
    $ 54.94万
  • 项目类别:
Inflammation Phenotypes in Pediatric Sepsis Induced Multiple Organ Failure Renewal
小儿脓毒症引起的多器官衰竭更新的炎症表型
  • 批准号:
    10017690
  • 财政年份:
    2014
  • 资助金额:
    $ 54.94万
  • 项目类别:

相似海外基金

Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 54.94万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mighty Accounting - Accountancy Automation for 1-person limited companies.
Mighty Accounting - 1 人有限公司的会计自动化。
  • 批准号:
    10100360
  • 财政年份:
    2024
  • 资助金额:
    $ 54.94万
  • 项目类别:
    Collaborative R&D
Accounting for the Fall of Silver? Western exchange banking practice, 1870-1910
白银下跌的原因是什么?
  • 批准号:
    24K04974
  • 财政年份:
    2024
  • 资助金额:
    $ 54.94万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
CPS: Medium: Making Every Drop Count: Accounting for Spatiotemporal Variability of Water Needs for Proactive Scheduling of Variable Rate Irrigation Systems
CPS:中:让每一滴水都发挥作用:考虑用水需求的时空变化,主动调度可变速率灌溉系统
  • 批准号:
    2312319
  • 财政年份:
    2023
  • 资助金额:
    $ 54.94万
  • 项目类别:
    Standard Grant
A New Direction in Accounting Education for IT Human Resources
IT人力资源会计教育的新方向
  • 批准号:
    23K01686
  • 财政年份:
    2023
  • 资助金额:
    $ 54.94万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An empirical and theoretical study of the double-accounting system in 19th-century American and British public utility companies
19世纪美国和英国公用事业公司双重会计制度的实证和理论研究
  • 批准号:
    23K01692
  • 财政年份:
    2023
  • 资助金额:
    $ 54.94万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An Empirical Analysis of the Value Effect: An Accounting Viewpoint
价值效应的实证分析:会计观点
  • 批准号:
    23K01695
  • 财政年份:
    2023
  • 资助金额:
    $ 54.94万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Accounting model for improving performance on the health and productivity management
提高健康和生产力管理绩效的会计模型
  • 批准号:
    23K01713
  • 财政年份:
    2023
  • 资助金额:
    $ 54.94万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
New Role of Not-for-Profit Entities and Their Accounting Standards to Be Unified
非营利实体的新角色及其会计准则将统一
  • 批准号:
    23K01715
  • 财政年份:
    2023
  • 资助金额:
    $ 54.94万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
通过系统地核算测量误差来改善特定年龄和特定原因的五岁以下死亡率 (ACSU5MR),为低收入国家的儿童生存决策提供信息
  • 批准号:
    10585388
  • 财政年份:
    2023
  • 资助金额:
    $ 54.94万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了